Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | -50.00% | -.--% | -.--% |
2022 | FluoroPharma Medical, Inc. Announces Executive Changes | CI |
2022 | FluoroPharma Medical, Inc. Appoints Frank I Igwealor as CFO | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ambrose Egbuonu
CEO | Chief Executive Officer | - | 15/05/22 |
Frank Igwealor
DFI | Director of Finance/CFO | 53 | 15/05/22 |
Chairman | 78 | 13/02/11 | |
Edward L. Lyons
PRN | Corporate Officer/Principal | - | 27/10/13 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 78 | 13/02/11 | |
William Lewis
BRD | Director/Board Member | 48 | 05/11/15 |
Frank Igwealor
DFI | Director of Finance/CFO | 53 | 15/05/22 |
Ambrose Egbuonu
CEO | Chief Executive Officer | - | 15/05/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 5,382,071 | 0 | 0 | 99.97 % |
Stock B | 1 | 34,262,264 | 34,262,264 ( 100.00 %) | 0 | |
Stock C | 0 | 9,370 | 0 | 0 |
Company contact information
FluoroPharma Medical, Inc.
701 South Carson Street Suite 200
89701, Carson City
+
Sector
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.76K | |
+0.67% | 42.4B | |
+44.30% | 40.04B | |
-6.20% | 28.31B | |
+6.55% | 24.94B | |
-21.66% | 18.96B | |
+29.96% | 12.3B | |
-1.57% | 11.95B | |
+16.03% | 11.32B | |
-4.80% | 11.55B |
- Stock Market
- Equities
- FPMI Stock
- Company FluoroPharma Medical, Inc.